BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 2
• 3
• 4
• 5
• 6
• 9
• 10
• 11
• 12
• 13
• 16
• 17
• 18
• 19
• 20
• 23
• 24
• 25
• 26
• 27
• 30

• Policy

  European Union’s CHMP Issues Positive Opinion on Schering-Plough Corporation’s Post-op Drug Sugammadex

  June 3, 2008

   · 

  6 min read
• Drug Development

  Seattle Genetics, Inc. Reports Multiple Complete and Partial Responses with SGN-35 in Patients with Lymphoma

  June 3, 2008

   · 

  1 min read
• Genesis Pharmaceuticals Enterprises, Inc. Closes $30 Million Private Note Placement

  June 3, 2008

   · 

  5 min read
• Drug Development

  Protalix Biotherapeutics to Initiate an Open-Label Extension Study for the Phase III Clinical Trial of prGCD

  June 3, 2008

   · 

  1 min read
• Business

  VeraLight Secures $20 Million Series C Financing

  June 3, 2008

   · 

  4 min read
• Drug Development

  Altus Pharmaceuticals Inc. Reports ALTU-237 Phase 1 Clinical Trial Results

  June 3, 2008

   · 

  1 min read
• Business

  Roche NimbleGen, Inc and BioDiscovery, Inc. Form Strategic Alliance to Enhance CGH Microarrays, Software and Services

  June 3, 2008

   · 

  4 min read
• Business

  Zymeworks’ ZymeCAD(TM) Platform for Protein Engineering to be Evaluated by DSM

  June 3, 2008

   · 

  1 min read
• Drug Development

  Critical Therapeutics, Inc. Completes Phase II Clinical Trial for Zileuton Injection

  June 3, 2008

   · 

  1 min read
• Business

  Axio Research Corporation (Aquired by Solutia, Inc Scientific Director Named a Fellow of the Society for Clinical Trials

  June 3, 2008

   · 

  1 min read